OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient…
With One Blood Test Pre-Treatment, PROphet® Provides Response Probability for the First Year of Treatment, Plus Analysis of Resistance Associated…